ARTICLE | Company News
Zyomyx diagnostic news
March 31, 2014 7:00 AM UTC
Zyomyx received $7.5 million from the World Health Organization's international drug purchase facility, UNITAID, to commercialize Zyomyx's MyT4 point-of-care CD4 test. The test identifies the conce...